RELIEF CARDIOVASCULAR REPORTS POSITIVE FIRST-IN-HUMAN DATA FOR DEVICE-BASED DECONGESTION THERAPY IN HEART FAILURE PATIENTS

Relief Cardiovascular, Inc., a private medical device company developing intelligent device-based therapy solutions for heart failure (HF) congestion, today announced positive 90-day results from the ...
TCTMD

TCT 1810: Percutaneous Coronary Intervention Supported by a Pulsatile Hemodynamic Assist Device in a Patient With Severe Ventricular Dysfunction and Severe Coronary Disease

TCT 1620: First-in-Human Use of an Oscor Breezeway Adelente Catheter to Optimize Support During the Implantation of an A-Flux Device in a Challenging Anatomy Receive the the latest news, research, and ...